ArticleCancer gene therapy2012

Modifications to the INSM1 promoter to preserve specificity and activity for use in adenoviral gene therapy of neuroendocrine carcinomas.

V Akerstrom et al.PubMed ↗Publisher ↗

No numbers read from the abstract.